` 603998 (Hunan Fangsheng Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

603998
vs
S
Shanghai Composite

Over the past 12 months, Hunan Fangsheng Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +2% compared to the Shanghai Composite's +15% growth.

Stocks Performance
603998 vs Shanghai Composite

Loading
603998
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603998 vs Shanghai Composite

Performance Gap Between 603998 and SSEC
HIDDEN
Show

Performance By Year
603998 vs Shanghai Composite

Loading
603998
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Hunan Fangsheng Pharmaceutical Co Ltd vs Peers

Shanghai Composite
603998
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.9B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Hunan Fangsheng Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top